Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by ledzep4uon Apr 05, 2023 11:41am
170 Views
Post# 35381132

Here Comes The $2's

Here Comes The $2'sI didn't think CURA could get to this level in $'s and a 14 RSI which I've never seen in any of my stocks and I've been doing this a long time. The CSE uplisting in May will do very little as pot will still be federally illegal so most institutions will still not be able to buy and banks still won't lend. All the news regarding UK and Germany has done and will probably do very little.

The disaster with their financial statements has really hurt this stock. And Boris is nowhere to be seen, just rehashing the press releases on Twitter and had also done nothing to help this stock. He has lack of credibility after trying to protray himself as a Washington insider with his year end prediction of SAFE passing, when he had no clue.

The only thing that will help this stock, is a good 2022 financial report release (whever that may be, but must be by end of April) which I doubt or the passage of SAFE or de-scheduling which won't happen for months.

Shorts are in total control and will take this down to the $2's. GLTA






<< Previous
Bullboard Posts
Next >>